In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

Zantac became the world’s best-selling medicine in 1988 and one of the first to top US$1 billion in annual sales. (Getty Images/AFP pic) CHICAGO: ...

However, former Zantac makers GSK, Pfizer, Sanofi and Boehringer Ingelheim had argued that the expert witnesses’ opinions lacked scientific support. The lawsuits have been an overhang for the company, ...

GSK’s discontinued heartburn drug Zantac allegedly contains a probable carcinogen. (Getty Images/AFP pic) LONDON: Shares of GSK dropped more than 9% today, after a Delaware judge allowed more ...

The science that led to Zantac’s withdrawal is very different from the basis of the recently dismissed Zantac litigation (“The Zantac Scare and Junk Science,” Review & Outlook, Dec. 9). The ...

“We think the outcome is worse than expected by market with stock having rallied 22% this year partly due to hope of near-term Zantac resolution in GSK’s favour.” Unlike GSK, Sanofi’s exposure is seen ...

The press typically treats lawsuits against business as inherently righteous and amplifies the junk science behind them. So in case you missed it, a federal judge on Tuesday dismissed claims that ...

The development of Zantac lawsuits continues as the risks related to the use of the drug are increasingly reported and it has become one of the most talked about lawsuits in the US. “Zantac” is the ...